BJO at a glance
WHAT DO WE DO ABOUT DIABETES?
Despite improvements in the medical management of patients with diabetes, as well as improved surgical and laser techniques to treat diabetic retinopathy, visual loss related to diabetes remains a major healthcare problem. Understanding the mechanism of diabetic retinopathy may be important in order to develop new treatments. Adamis outlines the case for diabetic retinopathy having a prominent inflammatory component. He cautions that much work is yet to be done but makes a strong case for inflammation playing a major part in the vast changes related to diabetes. Anti-inflammatory drug testing in human diabetic retinopathy is already under way.
Klein and Klein detail the case for more careful management of hypertension associated with diabetes: 30% of younger patients with diabetes and …
